ES03619/ES/NIEHS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1988	1
1989	2
1990	1
1991	4
1993	1
1994	7
1995	5
1996	4
1997	5
1998	4
1999	4
2000	2
2001	4
2003	2
2004	3
2005	4
2006	3
2007	5
2008	2
2009	1
2010	1
2024	0

1

Selective inhibitors of cytochromes P450.

Halpert JR, Guengerich FP, Bend JR, Correia MA. Halpert JR, et al. Toxicol Appl Pharmacol. 1994 Apr;125(2):163-75. doi: 10.1006/taap.1994.1061. Toxicol Appl Pharmacol. 1994. PMID: 8171425 Review.

2

Structure-function analysis of cytochromes P450 2B.

Zhao Y, Halpert JR. Zhao Y, et al. Biochim Biophys Acta. 2007 Mar;1770(3):402-12. doi: 10.1016/j.bbagen.2006.07.006. Epub 2006 Jul 22. Biochim Biophys Acta. 2007. PMID: 16935426 Review.

3

Structural basis of selective cytochrome P450 inhibition.

Halpert JR. Halpert JR. Annu Rev Pharmacol Toxicol. 1995;35:29-53. doi: 10.1146/annurev.pa.35.040195.000333. Annu Rev Pharmacol Toxicol. 1995. PMID: 7598496 Review.

4

Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Kumar S. Kumar S. Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):115-31. doi: 10.1517/17425250903431040. Expert Opin Drug Metab Toxicol. 2010. PMID: 20064075 Free PMC article. Review.

5

Molecular modeling of mammalian cytochromes P450: application to study enzyme function.

Szklarz GD, Graham SE, Paulsen MD. Szklarz GD, et al. Vitam Horm. 2000;58:53-87. doi: 10.1016/s0083-6729(00)58021-2. Vitam Horm. 2000. PMID: 10668395 Review.

6

Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy.

Szklarz GD, Halpert JR. Szklarz GD, et al. Drug Metab Dispos. 1998 Dec;26(12):1179-84. Drug Metab Dispos. 1998. PMID: 9860924 Review.

7

Thermodynamics of ligand binding to P450 2B4 and P450eryF studied by isothermal titration calorimetry.

Muralidhara BK, Halpert JR. Muralidhara BK, et al. Drug Metab Rev. 2007;39(2-3):539-56. doi: 10.1080/03602530701498182. Drug Metab Rev. 2007. PMID: 17786637 Review.

8

Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450.

Szklarz GD, Halpert JR. Szklarz GD, et al. Life Sci. 1997;61(26):2507-20. doi: 10.1016/s0024-3205(97)00717-0. Life Sci. 1997. PMID: 9416773 Review.

9

Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts.

Kumar S, Halpert JR. Kumar S, et al. Biochem Biophys Res Commun. 2005 Dec 9;338(1):456-64. doi: 10.1016/j.bbrc.2005.08.080. Epub 2005 Aug 22. Biochem Biophys Res Commun. 2005. PMID: 16126165 Review.

10

Secobarbital-mediated inactivation of cytochrome P450 2B1 and its active site mutants. Partitioning between heme and protein alkylation and epoxidation.

He K, He YA, Szklarz GD, Halpert JR, Correia MA. He K, et al. J Biol Chem. 1996 Oct 18;271(42):25864-72. doi: 10.1074/jbc.271.42.25864. J Biol Chem. 1996. PMID: 8824218 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year